13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2020-12-02 Event — SEC 0001493152-20-022835 →

Drexler Ryan Charles → MusclePharm Corp

Stake: — Shares: —
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100
  • Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
10 13D/G filings on this issuer
9 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest
—
Not in latest FINRA snapshot

Other 13D/G Filings on MusclePharm Corp

FiledFormFilerStakeShares
2022-04-01 SC White Winston Select Asset Fund Series Fund MP-18, LLC — — view →
2022-02-22 SC White Winston Select Asset Fund Series Fund MP-18, LLC — — view →
2020-11-03 SC WYNNEFIELD PARTNERS SMALL CAP VALUE LP I — — view →
2020-10-28 SC WYNNEFIELD PARTNERS SMALL CAP VALUE LP I — — view →
2019-11-08 SC White Winston Select Asset Fund Series Fund MP-18, LLC — — view →
2019-10-07 SC White Winston Select Asset Fund Series Fund MP-18, LLC — — view →
2019-09-18 SC Drexler Ryan Charles — — view →
2019-03-12 SC WYNNEFIELD PARTNERS SMALL CAP VALUE LP I — — view →
2018-01-03 SC WYNNEFIELD PARTNERS SMALL CAP VALUE LP I — — view →

Other Filings by Drexler Ryan Charles

FiledFormIssuerStakeShares
2019-09-18 SC MusclePharm Corp — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →